Skip Navigation



Annals of Oncology Advance Access published online on November 4, 2009
Annals of Oncology, doi:10.1093/annonc/mdp500
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mandala, M.
Right arrow Articles by Labianca, R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mandala, M.
Right arrow Articles by Labianca, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

editorial

Video meliora proboque sed deteriora sequor: the case of thromboprophylaxis in hospitalized cancer patients

M. Mandala1, A. Falanga2 and R. Labianca1,*

1 Divisions of Medical Oncology
2 Divisions of Immunohematology/Trasfusion Medicine, Hemostasis and Thrombosis Center, Department of Oncology/Hematology, Ospedali Riuniti, Bergamo, Italy

* (E-mail: rlabian@tin.it)

The first 150 words of the full text of this article appear below.

Publio Ovidio Naso was a Latin poet and had a deep knowledge of the human mind. To describe the human natural inclination to make mistakes, he wrote the famous phrase: ‘I see the best way and approve it, but I follow the worse one’ (video meliora proboque sed deteriora sequor).

This ancient statement might apply as well to the current clinical management of venous thromboembolism (VTE) in cancer patients, and, who knows, Ovidio was also referring to the natural propensity of Latin doctors to ignore the potential dramatic problem of VTE complication. He never would have thought that this error would persist prolonged till our days!

The history of VTE and cancer begins with Trousseau in 1865 when he first described the high incidence of VTE in patients with gastrointestinal carcinoma. Thereafter it has been extensively recognized that VTE is a common complication of patients with malignancy [1].

. . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?